Search results
Ronnie O'Sullivan and lookalike daughter Lilly attend Wimbledon day 2
Daily Mail· 2 hours agoRonnie O'Sullivan and his lookalike daughter Lilly were spotted in the Royal Box at Wimbledon on...
Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
Yahoo Finance· 10 minutes agoNovo CEO Lars Jørgensen has agreed to testify before Sanders' committee in late September. But the...
FDA approves a second Alzheimer's drug that can modestly slow disease
Associated Press via Yahoo News UK· 2 hours agoThe Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of...
Eli Lilly Alzheimer's drug approved by US FDA
Reuters via Yahoo Finance UK· 2 hours agoThe U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for slowing...
New Drug Approved for Early Alzheimer’s
New York Times· 2 hours agoThe drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the...
Lilly Wins FDA Approval for New Drug to Slow Alzheimer’s Disease
Bloomberg· 2 hours agoHave a confidential tip for our reporters? Eli Lilly & Co.’s Alzheimer’s treatment was cleared in...
Novo Nordisk, Lilly must cut prices of weight-loss drugs, Biden says in USA Today
Reuters· 7 hours agoU.S. President Joe Biden and Senator Bernie Sanders called on Novo Nordisk and Eli Lilly to reduce...
Novo, Lilly Slide After Biden Calls for Cheaper Obesity Drugs
Bloomberg via Yahoo Finance UK· 2 hours ago(Bloomberg) -- Novo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden...
Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment
The Wall Street Journal· 2 hours agoLilly's Kisunla was shown in a study to slow the decline of Alzheimer's patients.
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease | CNN
CNN.com· 43 minutes agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to...